Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHBIIT 99.1 TO FORM 8-K - VERU INC. | ex991toform8k.htm |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
__________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 4, 2013
|
THE FEMALE HEALTH COMPANY
|
|
(Exact name of registrant as specified in its charter)
|
|
Wisconsin
|
|
(State or other jurisdiction of incorporation)
|
|
1-13602
|
39-1144397
|
|
|
(Commission File Number)
|
(I.R.S. Employer I.D. Number)
|
|
515 North State Street
Suite 2225
Chicago, Illinois
|
60654
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
312-595-9123
|
|
(Registrant's telephone number, including area code)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR230.425) | |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 5 – Corporate Governance and Management
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On September 4, 2013, Michael R. Walton delivered notice that he will retire from the Board of Directors of The Female Health Company effective as of September 9, 2013. A copy of the press release announcing Mr. Walton's retirement is attached as Exhibit 99.1 to this report.
Section 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit 99.1 – Press Release of The Female Health Company, issued September 10, 2013.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE FEMALE HEALTH COMPANY
Date: September 10, 2013
BY /s/ Michele Greco
Michele Greco, Vice President and
Chief Financial Officer
3